Here we aimed to define the impact of MYCN activity in the context of retinoblastoma subtypes 1 and 2 in a cohort of 61 retinoblastoma samples enriched by six RB1-proficient MYCNA and two extraocular metastatic relapse samples. Here, MYCN is linked to retinoblastoma.